Cryptococcaemia: Clinical features and prognostic factors

QJM: An International Journal of Medicine

Volumn 95, Issue 8, 2002, Pages 511-518

  Jean, S S ^a   Fang, C T ^a   Shau, W Y ^b   Chen, Y C ^a   Chang, S C ^a   Hsueh, P R ^a   Hung, C C ^a   Luh, K T ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CORTICOSTEROID; CYTOTOXIC AGENT; FLUCONAZOLE; FLUCYTOSINE; IMMUNOSUPPRESSIVE AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD CULTURE; CEREBROSPINAL FLUID CULTURE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DEMOGRAPHY; FATALITY; FEMALE; FUNGUS ISOLATION; GENDER; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD; MENINGITIS; MORTALITY; MYCOSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; STATISTICAL ANALYSIS; SURVIVAL RATE; TAIWAN; UNIVERSITY HOSPITAL;

EID: 0036678182     PISSN: 14602725     EISSN: None     Source Type: Journal    
DOI: 10.1093/qjmed/95.8.511     Document Type: Article

References (36)

1. Cryptococcus neoformans
2. Fungal infections in the immunocompromised host
3. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome
4. Cryptococcosis: Population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons
5. Cryptococcal meningitis: Outcome in patients with AIDS and patients with neoplastic disease
6. Cryptococcal meningitis in AIDS
7. Cryptococcal meningitis in non-HIV-infected patients
8. Prognostic factors in cryptococcal meningitis: A study in 111 cases
9. Clinical features and in vitro susceptibilities of two varieties of Cryptococcus neoformans in Taiwan
10. Bacteremia and fungemia in patients with the acquired immunodeficiency syndrome
11. Fever and human immunodeficiency virus infection as sentinels for emerging mycobacterial and fungal blood-stream infections in hospitalized patients ≥ 15 years old, Bangkok
12. Diagnostic and prognostic value of clinical and laboratory findings in cryptococcal meningitis
13. Profound T-lymphocytopenia and cryptococcemia in a human immunodeficiency virus-seronegative patient with disseminated tuberculosis
14. Disseminated cryptococcosis diagnosed on peripherial blood smear in a patient with acquired immunodeficiency syndrome
15. Recovery from cryptococcemia and the adult respiratory distress syndrome in the acquired immunodeficiency syndrome
16. Cure of cryptococcemia and preservation of graft function in a renal transplant recipient
17. Cure of cryptococcemia in an immunocompromised patient with lupus nephritis
18. Cryptococcal meningitis: Cure despite cryptococcemia
19. Cryptococcemia
20. Candidemia in cancer patients: A prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
21. Candida, Cryptococcus, and other yeasts of medical importance
22. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis
23. APACHE II: A severity of disease classification system
24. Gram-negative bacteremia
25. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
26. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome
27. Diagnosis and management of increased intracranial pressure in patients with AIDS and cryptococcal meningitis
28. Cirrhosis: A risk factor for cryptococcal peritonitis
29. Serum bactericidal and opsonic activities in patients with non-alcoholic cirrhosis
30. Defective chemotaxis associated with a serum inhibitor in cirrhotic patients
31. Studies on lymphocyte hyporesponsiveness in cirrhosis: The role of increased monocyte suppressor cell activity
32. Cyclosporine A inhibits the growth of Cryptococcus neoformans in a murine model
33. Bloodstream infections in liver transplant recipients receiving tacrolimus
34. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis
35. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America